Products & Pipeline
Drug Discovery Pipeline
Our drug discovery pipeline is a dynamic portfolio of ongoing projects and clinical research initiatives aimed at transforming previously unsolvable diseases. From early-stage discovery to advanced clinical trials, we are methodically advancing candidate therapies that leverage our miRNA and DNA repair technology. This pipeline includes therapies designed to address a wide range of conditions, from age-related diseases to genetic disorders, positioning us for future regulatory approvals and global commercialization.
Commercialized Products
LIVIUS has successfully translated our cutting-edge technology into a range of market-ready products. Our commercial offerings include innovative cosmetic formulations and quasi-drugs that harness the power of cell reprogramming technology. These products not only rejuvenate cells and repair DNA damage but also deliver visible improvements in skin health and appearance. Each product is developed with rigorous scientific validation, ensuring safety and efficacy for everyday use.
Case Studies
We believe in evidence-based success. Our case studies highlight real-world examples of how our technology has delivered tangible benefits. For instance, one case study demonstrates the significant rejuvenation of aged cells, restoring both function and vitality while correcting DNA mutations. Another showcases the efficacy of our cosmetic line in improving skin texture and reducing visible signs of aging. These case studies underscore our commitment to developing safe, effective treatments that address complex health challenges, reinforcing the transformative potential of our technology.